• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2013 - 2019年墨西哥人乳头瘤病毒筛查覆盖率的空间流行病学

Spatial Epidemiology of Human Papillomavirus Screening Coverage in Mexico, 2013-2019.

作者信息

Palacios Rodríguez Oscar Alejandro, Galarde López Miguel, Quezada Sánchez Carlos, Reyna Sevilla Antonio

机构信息

Faculty of Psychology, Autonomous University of San Luis Potosí, San Luis Potosi, Mexico.

National Center for Disciplinary Research in Animal Health and Safety, National Institute of Forestry, Agricultural and Livestock Research, Mexico City, Mexico.

出版信息

Asian Pac J Cancer Prev. 2025 Jan 1;26(1):215-224. doi: 10.31557/APJCP.2025.26.1.215.

DOI:10.31557/APJCP.2025.26.1.215
PMID:39874004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12082424/
Abstract

OBJECTIVE

We aimed to assess the coverage of a Human Papillomavirus (HPV) screening program for each of the 32 federal states of Mexico, as well as the spatial patterns for HPV infections from 2013 to 2019.

METHODS

We conducted an exploratory, ecological study on data from a national health program in Mexico during 2013-2019. Adjusted rates per 100,000 females aged 25-64 years were estimated and georeferenced at the national and state level to assess the coverage of the screening program and positive detections of HPV infections. Cluster analysis was used to identify the location, magnitude, and trends of spatial patterns (p <0.05) by year and state.

RESULTS

2,529,819 screening tests for HPV detection were analyzed (2013-2019). A prevalence of HPV positivity of 11.1% (n= 228,582) was estimated. The number of HPV screening tests decreased from 2,835.4 (2013) to 0.8 (2019) per 100,000 females aged 25 to 64. HPV detection also showed a downward trend. A cluster (p <0.05) associated with a higher probability of detecting HPV infections was identified, comprised of territorially close states.

CONCLUSION

A decreased coverage of the HPV screening program and geographic differences were identified, suggesting that the existing strategies to prevent and detect HPV infections to accelerate cervical cancer elimination in Mexico need to be further reconsidered.

摘要

目的

我们旨在评估墨西哥32个联邦州中每个州的人乳头瘤病毒（HPV）筛查项目的覆盖率，以及2013年至2019年期间HPV感染的空间模式。

方法

我们对2013 - 2019年期间墨西哥一项国家卫生项目的数据进行了探索性生态研究。估计了每10万名25 - 64岁女性的调整率，并在国家和州层面进行地理定位，以评估筛查项目的覆盖率和HPV感染的阳性检测率。采用聚类分析按年份和州确定空间模式的位置、规模和趋势（p<0.05）。

结果

分析了2529819次HPV检测筛查（2013 - 2019年）。估计HPV阳性患病率为11.1%（n = 228582）。每10万名25至64岁女性的HPV筛查检测次数从2013年的2835.4次降至2019年的0.8次。HPV检测也呈下降趋势。确定了一个与检测到HPV感染的较高概率相关的聚类（p<0.05），由地理位置相近的州组成。

结论

确定了HPV筛查项目覆盖率下降和地理差异，这表明墨西哥现有的预防和检测HPV感染以加速消除宫颈癌的策略需要进一步重新考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132d/12082424/487fe58442d9/APJCP-26-215-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132d/12082424/8b64b688e99b/APJCP-26-215-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132d/12082424/5157ca780352/APJCP-26-215-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132d/12082424/2b36ffffedcf/APJCP-26-215-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132d/12082424/6ab46ca3b3fc/APJCP-26-215-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132d/12082424/a6e1339dca9b/APJCP-26-215-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132d/12082424/487fe58442d9/APJCP-26-215-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132d/12082424/8b64b688e99b/APJCP-26-215-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132d/12082424/5157ca780352/APJCP-26-215-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132d/12082424/2b36ffffedcf/APJCP-26-215-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132d/12082424/6ab46ca3b3fc/APJCP-26-215-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132d/12082424/a6e1339dca9b/APJCP-26-215-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/132d/12082424/487fe58442d9/APJCP-26-215-g006.jpg

相似文献

1
Spatial Epidemiology of Human Papillomavirus Screening Coverage in Mexico, 2013-2019.2013 - 2019年墨西哥人乳头瘤病毒筛查覆盖率的空间流行病学
Asian Pac J Cancer Prev. 2025 Jan 1;26(1):215-224. doi: 10.31557/APJCP.2025.26.1.215.
2
The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women.人乳头瘤病毒基因分型检测在日本女性自行采集的尿液和阴道样本癌症筛查中的效用
Gynecol Obstet Invest. 2025;90(2):143-152. doi: 10.1159/000541641. Epub 2024 Oct 7.
3
Exponential uptake of HPV self-collected cervical screening testing 2 years since universal availability in Victoria, Australia.自澳大利亚维多利亚州全面推行人乳头瘤病毒（HPV）自我采集宫颈筛查检测两年以来，其接受率呈指数级增长。
BMC Med. 2025 Jul 1;23(1):389. doi: 10.1186/s12916-025-04219-3.
4
[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].[卫生技术评估报告。液基细胞学在宫颈癌前病变筛查中的应用]
Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 2):e1-e33.
5
Characteristics of Human Papillomavirus Prevalence and Infection Patterns Among Women Aged 35-65 in Fujian Province, China: A Nine-Year Retrospective Observational Study.中国福建省35至65岁女性人乳头瘤病毒流行特征及感染模式：一项九年回顾性观察研究
J Med Virol. 2025 Feb;97(2):e70238. doi: 10.1002/jmv.70238.
6
Cytology versus HPV testing for cervical cancer screening in the general population.普通人群宫颈癌筛查中细胞学检查与HPV检测的比较
Cochrane Database Syst Rev. 2017 Aug 10;8(8):CD008587. doi: 10.1002/14651858.CD008587.pub2.
7
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施，以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
8
A scoping review of human papillomavirus related data system in China.中国人类乳头瘤病毒相关数据系统的范围综述。
BMC Infect Dis. 2025 Jul 1;25(1):873. doi: 10.1186/s12879-025-11106-y.
9
Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force.液基细胞学检查和人乳头瘤病毒检测筛查宫颈癌：美国预防服务工作组的系统评价。
Ann Intern Med. 2011 Nov 15;155(10):687-97, W214-5. doi: 10.7326/0003-4819-155-10-201111150-00376. Epub 2011 Oct 17.
10
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.接种人乳头瘤病毒预防性疫苗以预防宫颈癌及其癌前病变。
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.

本文引用的文献

1
Prevalence of cervical human papillomavirus in Mexico, 2010-2017: analysis of 2.7 million women.2010 - 2017年墨西哥宫颈人乳头瘤病毒感染率：对270万女性的分析
Cancer Causes Control. 2023 Feb;34(2):123-132. doi: 10.1007/s10552-022-01642-2. Epub 2022 Oct 22.
2
Epidemiology and Molecular Biology of HPV Variants in Cervical Cancer: The State of the Art in Mexico.人乳头瘤病毒变体在宫颈癌中的流行病学和分子生物学：墨西哥的最新研究进展。
Int J Mol Sci. 2022 Aug 2;23(15):8566. doi: 10.3390/ijms23158566.
3
Prevalence and Distribution of Human Papillomavirus Genotypes (1997-2019) and Their Association With Cervical Cancer and Precursor Lesions in Women From Southern Mexico.
墨西哥南部女性的人乳头瘤病毒基因型（1997-2019 年）流行率和分布情况及其与宫颈癌和癌前病变的关系。
Cancer Control. 2022 Jan-Dec;29:10732748221103331. doi: 10.1177/10732748221103331.
4
High frequency of HPV genotypes 59, 66, 52, 51, 39 and 56 in women from Western Mexico.在来自墨西哥西部的女性中 HPV 基因型 59、66、52、51、39 和 56 的高频率。
BMC Infect Dis. 2020 Nov 25;20(1):889. doi: 10.1186/s12879-020-05627-x.
5
Human papilloma virus (HPV) profiles in breast cancer: future management.乳腺癌中的人乳头瘤病毒（HPV）概况：未来的管理
Ann Transl Med. 2020 May;8(10):650. doi: 10.21037/atm-19-2756.
6
High prevalence of human papillomavirus and European variants of HPV 16 infecting concomitantly to cervix and oral cavity in HIV positive women.人乳头瘤病毒（HPV）和 HPV16 欧洲型在 HIV 阳性妇女的宫颈和口腔中同时高发。
PLoS One. 2020 Apr 22;15(4):e0227900. doi: 10.1371/journal.pone.0227900. eCollection 2020.
7
The role of HPV infection in oropharyngeal cancer.人乳头瘤病毒（HPV）感染在口咽癌中的作用。
Rom J Morphol Embryol. 2019;60(3):769-773.
8
Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico.墨西哥 HPV 基于筛查中 HPV-16 和 HPV-18 基因分型与细胞学检测的比较：作为分流检测方法。
JAMA Netw Open. 2019 Nov 1;2(11):e1915781. doi: 10.1001/jamanetworkopen.2019.15781.
9
Mutational landscape and intra-host diversity of human papillomavirus type 16 long control region and E6 variants in cervical samples.宫颈样本中人乳头瘤病毒 16 型长控制区和 E6 变异体的突变景观和宿主内多样性。
Arch Virol. 2019 Dec;164(12):2953-2961. doi: 10.1007/s00705-019-04407-6. Epub 2019 Sep 24.
10
Nail squamous cell carcinoma: A hidden high-risk human papillomavirus reservoir for sexually transmitted infections.甲鳞状细胞癌：性传播感染的隐藏高危人乳头瘤病毒储库。
J Am Acad Dermatol. 2019 Dec;81(6):1358-1370. doi: 10.1016/j.jaad.2019.03.070. Epub 2019 Mar 29.